Abstract
The identification of Gc (vitamin D binding protein) with the anionic polypeptide cochemotaxin has recently been reported. In this paper we investigate its dose dependent cochemotactic activity and report the inhibition of Gc enhanced Chemotaxis by vitamin D3. These results further support the role of immunomodulating hormone played by vitamin D.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Petrini M., Galbraith R.M., Werner P.A.M., Emerson D.L., Arnaud P. Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B cell membranes. Clin. Immunol. Immunopathol. 31: 282, 1984.
Petrini M., Emerson D.L., Galbrith R.M. Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein. Nature 306: 73, 1983.
Nel A.E., Navailles M., Emerson D.L., Goldschmidt-Clermont P.J., Pathak S.K., Tsang K.Y., Galbraith R.M. Alterated configuration of Gc protein on the plasma membrane of transformed and malignant human B lymphocytes. Clin. Immunol. Immunopathol. 37: 191, 1985.
Machii T., Kimura H., Ueda E., Chujo T., Morita T., Katagiri S., Tagawa S., Kitani T. Distribution of Gc protein (Vitamin D binding protein) on the surfaces of normal human lymphocytes and leukemic lymphocytes. Acta Halmatol. 75: 26, 1986.
Petrini M., Carulli G., Ambrogi F., Galbraith R.M. Phenotypic markers in chronic lymphocytic leukemia. N. Engl. J. Med. 314: 1514, 1986.
Petrini M., Galbraith R.M., Emerson D.L., Nel A.E., Arnaud P. Structural studies of T lymphocyte Fc receptors. Association of Gc protein with IgG binding to Fc gamma. J. Biol. Chem. 260: 1804, 1985.
Wooten M.W., Nel A.E., Goldschmidt-Clermont P.J., Galbraith R.M., Wrenn R.W. Identification of a major substrate for phospholipid/Ca++ dependent kinase in isolated pancreatic acini as Gc (vitamin D binding protein). FEBS Lett. 197: 97, 1985.
Van Baelen H., Bouillon R., De Moor P. Vitamin D binding protein (Gc globulin) binds actin. J. Biol. Chem. 255: 2270, 1980.
Haddad J.G. Human serum binding protein for vitamin D and its metabolites (DBP): evidence that actin is the DBP binding component in human skeletal. Arch. Biochem. Biophys. 213: 538, 1982.
Lees A., Haddad J.G., Lin S. Brevin and vitamin D binding protein: comparison of the effects of two serum proteins on actin assembly and disassembly. Biochemistry 23: 3038, 1985.
Goldschmidt Clermont P.J., Galbraith R.M., Emerson D.L., Marsot F., Nel A.E., Arnaud P. Distinct sites on the G actin molecule bind Gc and DNase I. Biochem. J. 228: 471, 1985.
Lind S.E., Smith D.B., Janmey P.A., Stossel T.P. Role of plasma gelsolin and the vitamin D binding protein in clearing actin from the circulation. J. Clin. Invest. 78: 736, 1986.
Goldschmidt-Clermont P.J., Van Baelen H., Bouillon R., Shook I.E., Williams M.H., Nel A.E., Galbraith R.M. Role of group specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit. J. Clin. Invest. 81: 1519, 1988.
Kew R.R., Webster R.O. Gc globulin (vitamin D binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J. Clin. Invest. 82: 364, 1988.
Perez H.D., Kelly E., Chenoweth D., Elfman F. Identification of the C5a des Arg chemotaxin. Homology with vitamin D binding protein (group specific component globulin). J. Clin. Invest. 82: 360, 1988.
Daiger S.P., Schanfield M.S., Cavalli — Sforza L.L. Group specific component (Gc) proteins bind vitamin D and 25-Hydroxy-vitamin D. Proc. Natl. Acad. Sci. USA 72: 2076, 1975.
Bouillon R., Van Kerkhove P., De Moor P. The measurement of 25-hydroxyvitamin D3 in serum. Clin. Chem. 22: 364, 1976.
Azzarà A., Petrini M., Carulli G., Polidori R., Ruocco L., Vaglini F., Trombi L., Mian M., Bertelli A., Ambrogi F. The effects of lithium and rubidium on human leucocyte functions. Int. J. Immunotherapy 2: 233, 1986.
Williams M.H., Van Alstyne E.L., Galbraith R.M. Evidence of a novel association of unsaturated fatty acids with Gc (vitamin D binding protein). Biochem. Biophys. Res. Commun. 153: 1019, 1988.
Prowedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1,25 dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181, 1983.
Tsoukas C.D., Provvedini D.M., Manolagas S.C. 1,25 dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 224: 1438, 1984.
Rigby W.F.C., Noelle R.J., Krause K., Fanger M.W. The effects of 1,25 dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J. Immunol. 135: 2279, 1985.
Chen W.C., Vayuvegula B., Gupta S. 1,25 dihydroxyvitamin D3 mediated inhibition of human B cell differentiation. Clin. Exp. Immunol. 69: 639, 1987.
Lemire J.M., Adams J.S., Sakai R., Jordan S.C. 1,25 dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest. 74: 657, 1984.
Rigby W.F.C., Denome S., Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25 dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 79: 1659, 1987.
Tobler A., Gasson J., Reichel H., Norman A.W., Koeffler H.P. Granulocyte Macrophage colony stimulating factor. Sensitive and receptor mediated regulation by 1,25 dihydroxyvitamin D3 in normal human peripheral blood lymphocytes. J. Clin. Invest. 79: 1700, 1987.
Manolagas S.C., Hustmyer F.G., Yu X.P. 1,25 dihydroxyvitamin D and the immune system (42915). Soc. Exp. Biol. Med. 37: 238, 1989.
Koeffler H.P., Reichel H., Bishop J.E., Norman A.W. Gamma interferon stimulates the production of 1,25-Dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun. 127: 596, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Petrini, M., Azzarà, A., Carulli, G. et al. 1,25-dihydroxycholecalciferol inhibits the cochemotactic activity of Gc (vitamin D binding protein). J Endocrinol Invest 14, 405–408 (1991). https://doi.org/10.1007/BF03349090
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349090